Part I. Telomerase levels in human metastatic brain tumors show four- fold logarithmic variability but no correlation with tumor type or interval to patient demise

Journal of the Neurological Sciences

Volumn 161, Issue 2, 1998, Pages 116-123

  Kleinschmidt DeMasters, B K ^a   Shroyer, A Laurie ^b   Hashizumi, Tanya L ^a   Evans, Lynnette C ^a   Markham, Neil ^a   Kindt, Glenn ^a   Shroyer, Kenneth R ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Brain; Central nervous system; Cerebrospinal fluid; Cytology; Melanoma; Metastasis; Prognosis; Telomerase

Indexed keywords

TELOMERASE;

ADULT; AGED; ARTICLE; BRAIN METASTASIS; CANCER MORTALITY; CANCER SURVIVAL; CELL IMMORTALIZATION; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CYTOLOGY; FEMALE; HUMAN; HUMAN TISSUE; MALE; MELANOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

ADULT; AGED; BRAIN NEOPLASMS; CARCINOMA; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MELANOMA; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TELOMERASE;

EID: 0032509134     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(98)00253-6     Document Type: Article

References (32)

1. Allison PD. Survival analysis using the SAS system. Cary NC: SAS Institute, 1995:9-60.
2. Axelrod N. Of telomeres and tumors. The enzyme, telomerase, may be switched on in tumor cells. Inhibitors of this enzyme might constitute a new class of anti-cancer drugs. Nature Med. 2:1996;158-159.
3. Blasco M.A., Rizen M., Greider C.W., Hanahan D. Differential regulation of telomerase activity and telomerase RNA during multi-stage tumorigenesis. Nature Genet. 12:1996;200-204.
4. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 72:1976;248-254.
5. Broccoli D., Young J.W., de Lange T. Telomerase activity in normal and malignant hematopoietic cells. Proc Natl Acad Sci USA. 92:1995;9082-9086.
6. Chadeneau C., Hay K., Hirte H.W., Gallinger S., Bacchetti S. Telomerase activity associated with acquisition of malignancy in human colorectal cancer. Cancer Res. 55:1995;2533-2536.
7. Counter C., Hirte H.W., Bacchette S., Harley C.B. Telomerase activity in human ovarian carcinoma. Proc Natl Acad Sci USA. 91:1994;2900-2904.
8. DeMasters B.K., Markham N., Lillehei K.O., Shroyer K.R. Differential telomerase expression in human primary intracranial tumors. Am J Clin Pathol. 107:1997;548-554.
9. Greider C.W., Blackburn E.H. Telomeres, telomerase and cancer. Sci Am. 274:1996;92-97.
10. Healy K.C. Telomere dynamics and telomerase activation in tumor progression: prospects for prognosis and therapy. Oncol Res. 7:1995;121-130.
11. Hiyama E., Gollahon L., Kataoka T., Kuroi K., Yokoyama T., Gazdar A.F.et al. Telomerase activity in human breast tumors. J Natl Cancer Inst. 88:1996;116-122.
12. Hiyama K., Hiyama E., Ishioka S., Yamakido M., Inai K., Gazdar A.F.et al. Telomerase activity in small-cell and non-small-cell lung cancers. J Natl Cancer Inst. 87:1995;895-902.
13. Hiyama E., Hiyama K., Yokoyama T., Matsuura Y., Piatyszed M.A., Shay J.W. Correlating telomerase activity levels with human neuroblastoma outcomes. Nature Med. 1:1995;249-255.
14. Hiyama E., Yokoyama T., Tatsumoto N., Hiyama K., Imamura Y., Murakami Y.et al. Telomerase activity in gastric cancer. Cancer Res. 55:1995;3258-3262.
15. Holliday R. Endless quest. BioEssays. 18:1996;3-5.
16. Iwama H., Ohyashiki K., Ohyashiki J.H., Hayashi S., Kawakubo K., Shay J.W.et al. The relationship between telomere length and therapy-associated cytogenetic responses in patients with chronic myeloid leukemia. Cancer. 79:1997;1552-1560.
17. Kannan S., Tahara H., Yokozaki H., Mathew B., Nalinakumari K.R., Nair M.K.et al. Telomerase activity in premalignant lesions of human oral mucosa. Cancer Epidemiol Biomarkers Prev. 6:1997;413-420.
18. Kim N.W., Piatyszek M.A., Prowse K.R., Harley C.B., West M.D., Ho P.L.et al. Specific association of human telomerase activity with immortal cells and cancer. Science. 266:1994;2011-2015.
19. Langford L.A., Piatyszek M.A., Xu R., Schold S.C. Jr., Shay J.W. Telomerase activity in human brain tumours. Lancet. 345:1995;1267-1268.
20. Langford L.A., Piatyszed M.A., Xu R., Schold S.C. Jr., Wright W.E., Shay J.W. Telomerase activity in ordinary meningiomas predicts poor outcome. Hum Pathol. 28:1997;416-420.
21. Lee ET. Statistical methods for survival data analysis. Belmont, CA: Lifetime Learning Publications, 1980:122-45.
22. McEachern M.J., Blackburn E.H. Runaway telomere elongation caused by telomerase RNA gene mutations. Nature. 376:1995;403-409.
23. Nakatani K., Yoshimi N., Mori H., Yoshimura S., Sakai H., Shinoda J.et al. The significant role of telomerase activity in human brain tumors. Cancer. 80:1997;471-476.
24. Parkinson E.K. Do telomerase antagonists represent a novel anti-cancer strategy? Br J Cancer. 73:1996;1-4.
25. Rogalla P., Kazmierczak B., Rohen C., Trams G., Bartnitzke S., Bullerdiek J. Two human breast cancer cell lines showing decreasing telomeric repeat length during early in vitro passaging. Cancer Genet Cytogenet. 77:1994;19-25.
26. Sharma H.W., Maltese J.Y., Zhu X., Kaiser H.E., Narayanan R. Telomeres, telomerase and cancer: is the magic bullet real? Anticancer Res. 16:1996;511-516.
27. Sharma H.W., Sokoloski J.A., Perez J.R., Maltese J.Y., Sartorelli A.C., Stein C.A.et al. Differentiation of immortal cells inhibits telomerase activity. Proc Natl Acad Sci USA. 92:1996;12343-12346.
28. Shroyer K.R., Stephens J.K., Silverberg S.G., Markham N., Shroyer A.L., Wilson M.et al. Telomerase expression in normal endometrium, endometrial hyperplasia, and endometrial adenocarcinoma. Int J Gynecol Pathol. 16:1997;225-232.
29. Sommerfelt H.J., Meeker A.K., Piatyszed M.A., Bova G.S., Shay J.W., Coffey C.S. Telomerase activity: a prevalent marker of malignant human prostate tissue. Cancer Res. 56:1996;218-222.
30. Tahara E., Semba S., Tahara H. Molecular biological observations in gastric cancer. Semin Oncol. 23:1996;307-315.
31. Taylor R.S., Ramirez R.D., Ogoshi M., Chaffins M., Piatyszed M.A., Shay J.W. Detection of telomerase activity in malignant and nonmalignant skin conditions. J Invest Dermatol. 106:1996;759-765.
32. Zhang W., Piatyszek M.A., Kobayashi T., Estey E., Andreeff M., Deisseroth A.B.et al. Telomerase activity in human acute myelogenous leukemia: inhibition of telomerase activity by differentiation-inducing agents. Clin Cancer Res. 2:1996;799-803.